South Korean Firms to Inject 10 Trillion Won into Biotechnology by 2023

President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon.

South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) ...

Samsung Biologics delivers first batch of Eli Lilly's COVID-19 antibody treatment.

Samsung Biologics to Manufacture Eli Lilly‘s COVID-19 Antibody Treatment

by KoreaTechToday Editor

November 17, 2020

Samsung Biologics announced on Tuesday that it successfully produced the first batch of Eli Lilly’s COVID-19 antibody treatment. This came ...

Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.

Samsung Biologics Signs 287 Bln Won CMO Supply Deal with GSK

by James Jung

May 22, 2020

Samsung Biologics Co. on Friday said that it signed an eight-year contract manufacturing organization (CMO) deal valued at 287 billion ...

Samsung Biologics signed with Vir Biotechnology a manufacturing agreement worth approximately $362 million to mass-produce COVID-19 treatment.

Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment

by James Jung

April 9, 2020

Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...

Samsung Biologics, Aprinoia Inks Deal to Develop Alzheimer’s Treatment

by KoreaTechToday Editor

March 17, 2020

Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...